No Data
Vaxcyte Insider Sold Shares Worth $649,325, According to a Recent SEC Filing
Andrew Guggenhime, President and CFO, on July 18, 2024, sold 8,000 shares in Vaxcyte (PCVX) for $649,325. Following the Form 4 filing with the SEC, Guggenhime has control over a total of 96,720
Russell Rotation: YTD Market Capitalizations Swelling for Small-caps
Vaxcyte Insider Sold Shares Worth $425,000, According to a Recent SEC Filing
Elvia Cowan, Senior Vice President, Finance, on July 16, 2024, sold 5,000 shares in Vaxcyte (PCVX) for $425,000. Following the Form 4 filing with the SEC, Cowan has control over a total of 12,723
Vaxcyte(PCVX.US) Officer Sells US$400K in Common Stock
$Vaxcyte(PCVX.US)$ Officer Cowan Elvia sold 5,000 shares of common stock on Jul 8, 2024 at an average price of $80 for a total value of $400K.Source: Announcement What is statement of changes in
Cargo Therapeutics Shares Rise on Sublease Deal With Vaxcyte
By Sabela Ojea Shares of Cargo Therapeutics rose 6.1% in post-market trading after the company entered a sublease agreement with Vaxcyte. The stock recently traded at $16.97. Shares are down about 31%
Form 144 | Vaxcyte(PCVX.US) Officer Proposes to Sell 400K in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 8, $Vaxcyte(PCVX.US)$ Officer Cowan Elvia intends to sell 5,000 shares of its common stock on Jul 8, with a total market value of approximately $400K.